Relmada Therapeutics (4E2.F) Q3 2024 Earnings

Aug 7Confirmed
Q2 2024
Q3 2024
-0.79
-0.71
-0.62
-0.54

Details

Expected EPS
-0.7575514250000001
Actual EPS
-0.5401273
Surprise EPS
0.22
Surprise Percent
+28.7%

Description

⁨Relmada Therapeutics⁩ (⁦4E2.F⁩) has reported earnings of ⁦-0.5401273⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts